Plain-English translation of NCT06860750 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can help adults with active non-radiographic axial spondyloarthritis—a type of inflammatory spine condition. The trial will compare the medication against a placebo (a fake injection that looks identical) to measure whether the treatment actually works and is safe. About 380 people will participate across multiple centers.
Many people with this spine condition experience pain and inflammation that limits their daily activities, and doctors are looking for new treatment options. This trial aims to determine whether this medication can effectively reduce symptoms and improve quality of life for patients who need better options.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive either the new medication or a placebo injection during an initial treatment period, then everyone will have the option to receive the actual medication in an extended period afterward. You'll visit the research clinic multiple times for injections and check-ups where doctors monitor how you're responding and watch for any side effects. The study involves blood tests, physical exams, and questions about your symptoms to see how the treatment is working for you.
AI-generated summary from trial data · Aug 20, 2026 · Not medical advice
China